PMID- 34990997 OWN - NLM STAT- MEDLINE DCOM- 20220303 LR - 20220303 IS - 1873-4529 (Electronic) IS - 0952-8180 (Linking) VI - 77 DP - 2022 May TI - Use of provider education, intra-operative decision support, and an email-feedback system in improving compliance with sugammadex dosage guideline and reducing drug expenditures. PG - 110627 LID - S0952-8180(21)00470-0 [pii] LID - 10.1016/j.jclinane.2021.110627 [doi] AB - STUDY OBJECTIVE: Due to excessive sugammadex expenditures at our institution, we designed dosing guidelines that utilize adjusted body weight and informatics-based tools aimed at reducing variability in dosing practices. DESIGN: We retrospectively reviewed rates of high-dose sugammadex administration in three phases: Pre-intervention - May 2018 to November 2018; First intervention - November 2018 to April 2019; and Second intervention - April 2019 to July 2019. SETTING: Academic medical center in the United States - Vanderbilt University Medical Center (VUMC) PATIENTS: N/A INTERVENTIONS: First, anesthesia providers were educated on adjusted body weight-based dosing guidelines. Providers also received intraoperative decision support displaying a patient's actual and adjusted body weight along with rates of high-dose (>200 mg) sugammadex administration for each respective provider. Second, we implemented an email-feedback system to remind providers of the new guidelines. MEASUREMENTS: Weekly rate of high-dose sugammadex cases. MAIN RESULTS: During the pre-intervention stage, 1556 (12.3%) cases involved high-dose sugammadex. Comparatively, 550 (4.3%) and 187 (3.1%) high-dose sugammadex cases occurred during the first and second intervention stages, respectively. Segmented regression analysis demonstrated a significant rate change of -3.51% (95% CI: -5.64%, -1.38%) in sugammadex dosing practices after provider education and the implementation of digital improvement initiatives but failed to reveal a significant change after implementation of the email-feedback system. Overall, our interventions were associated with $2563.05 in estimated weekly savings of sugammadex expenditures. CONCLUSIONS: Provider education and digital quality improvement was associated with reduced rates of high-dose sugammadex administration, generating cost savings at a large academic medical institution. CI - Copyright (c) 2021 Elsevier Inc. All rights reserved. FAU - Pregnall, Andrew M AU - Pregnall AM AD - Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA. FAU - Gupta, Rajnish K AU - Gupta RK AD - Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA. FAU - Clifton, Jacob C AU - Clifton JC AD - Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: jacob.c.clifton@vumc.org. FAU - Wanderer, Jonathan P AU - Wanderer JP AD - Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA. LA - eng PT - Journal Article DEP - 20220103 PL - United States TA - J Clin Anesth JT - Journal of clinical anesthesia JID - 8812166 RN - 0 (Pharmaceutical Preparations) RN - 361LPM2T56 (Sugammadex) RN - 3982TWQ96G (Neostigmine) SB - IM MH - Electronic Mail MH - Feedback MH - Health Expenditures MH - Humans MH - Neostigmine MH - *Neuromuscular Blockade MH - *Pharmaceutical Preparations MH - Retrospective Studies MH - Sugammadex OTO - NOTNLM OT - Cost OT - Neostigmine OT - Sugammadex EDAT- 2022/01/07 06:00 MHDA- 2022/03/04 06:00 CRDT- 2022/01/06 20:25 PHST- 2021/08/17 00:00 [received] PHST- 2021/12/01 00:00 [revised] PHST- 2021/12/02 00:00 [accepted] PHST- 2022/01/07 06:00 [pubmed] PHST- 2022/03/04 06:00 [medline] PHST- 2022/01/06 20:25 [entrez] AID - S0952-8180(21)00470-0 [pii] AID - 10.1016/j.jclinane.2021.110627 [doi] PST - ppublish SO - J Clin Anesth. 2022 May;77:110627. doi: 10.1016/j.jclinane.2021.110627. Epub 2022 Jan 3.